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ENDOVASCULAR AND SURGICAL TECHNIQUES 
The Varicid: A New Device for Saphenous Sclerotherapy 
P. Cadet  
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Introduction 
The varicid (Murat SA, 26340 Saillans, France) is a new 
instrument which allows effective sclerotherapy of the 
long saphenous vein during varicose vein surgery. 
This avoids the need for surgical stripping and 
provides a safe, effective and simple technique of 
varicose vein treatment. 
Methods 
Equipment 
The following equipment is required for this proce- 
dure (Fig. 1). 
(a) A 90cm long hollow plastic tube (T) of 2.5ram 
internal diameter. 
(b) A long lmm diameter solid plastic catheter of 
lmm diameter (F) with a cylindrical bulge (P) in 
its centre and a further bulge (B) at one end (the 
head). The shape of the head is shown in Fig. 1. 
Its lower part is cylindrical and fits onto the end 
of F, the middle part is cone shaped and the 
lower part of the cone has a right angled edge 
(b). On top of the cone is a small sphere which 
allows the head to be held through the skin at the 
ankle. 
(c) A filling chamber R. 
Preparation 
The following preparation technique for sclerotherapy 
is used: 
(a) Insert end E of catheter F into tube T through 
opening A. 
(b) Pass piston P through end A of the tubing T. 
(c) Pass the reservoir R over piston P. 
(d) Insert A into the lower opening of R. 
(e) Pour the sclerosant into reservoir R. 
(f) Pull E gently to lower the piston into the tube T 
and sclerosant will pass down with it. 
(g) Pull lower part of B into end A of tube. Fix a clip 
onto end C of the tube to prevent sclerosant 
leaking out and then cut F 2-3cm outside the 
tube T. 
(h) Remove the reservoir R. 
Technique 
The following technique is used to sclerose the vein 
once preparation is complete. 
(a) Ligate the saphenofemoral junction under local 
anaesthetic. 
(b) Introduce the varicid (end A and head B first) 
into the distal end of the divided long saphenous 
vein in the groin until the head is felt at the 
ankle. 
(c) Bandage the leg with an elastic compression 
bandage above the head of the varicid from the 
ankle to the upper thigh. 
(d) Remove the clip from tube T and F. 
(e) Holding the head of the varicid through the skin 
at the ankle pull the tube T out of the long 
saphenous vein. This will cause sclerosing fluid 
to drip slowly into the long saphenous vein 
lumen. 
(f) Remove the catheter F. 
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Discussion 
This is a procedure which uses an established treat- 
ment but with a new technique which allows safe and 
effective sclerosis of the long saphenous vein. Scler- 
otherapy of the long saphenous vein has been used all 
over the world for several decades with a variety of 
different sclerosants, and has been shown to be an 
effective treatment of varicose veins associated with 
long saphenous vein incompetence. However it 
requires multiple injections which may have to be 
repeated on a number of occasions. 
The varicid provides highly efficient sclerosis of the 
long saphenous vein using only a small volume of 
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Fig. 1. Preparation ofthe Varicid for use. 
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sclerosant, (4ml of 3% Sodium Tetradecyl Sulphate). 
Sclerosis by external injection would be difficult to 
achieve using this volume of sclerosant. 
Since September 1992 the varicid has been used by 
Dr Castalat at the Clinique Generale at Valence sur 
Rhone in France and also by Professor Maleti at the 
Institute of Surgical Pathology in Modena in Italy. 
More than 60 patients have been treated without 
complication except for occasional inflammation of 
the overlying stain. 
This technique differs from surgery alone in the 
following: 
(a) It can be performed under local anaesthetic. 
(b) The technique does not require stripping of the 
long saphenous vein with its associated morbid- 
ity but nevertheless destroys the long saphenous 
vein. 
(c) It avoids complications such as saphenous nerve 
damage, lymphatic injur~ and haematoma 
formation. 
(d) It avoids the need for avulsion incisions to 
remove the long saphenous vein below the 
knee. 
(e) The technique can be performed as an "out- 
patient" procedure. 
It differs from sclerotherapy alone in the 
following: 
(a) It avoids the need for multiple external injection 
sites. 
(b) It avoids thrombosis in the vein as the long 
saphenous vein is empty and the walls opposed 
prior to delivery of the sclerosant. 
(c) The sclerosing liquid is dripped into the vein 
regularly, one drop every centimetre, no matter 
at what speed the catheter is removed and 
provides an even distribution of sclerosant. 
(d) There is no risk of skin ulceration due to injection 
of sclerosant outside the vein. 
(e) There is no risk of intra-arterial injection. 
(f) There is total sclerosis and repeat reatments are 
not necessary because the saphenofemoral junc- 
tion is also ligated. 
In summary this technique allows delivery of 
sclerosant throughout the long saphenous vein and 
therefore destruction of the whole vein through a 
single groin incision with minimal morbidity. This is 
not achievable by other treatment methods. 
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